US Patent 9315811 Methods for modulating kallikrein (KLKB1) expression
Patent 9315811 was granted and assigned to Ionis Pharmaceuticals on April, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 8, 2012
0
Date of Patent
April 19, 2016
0
Patent Application Number
14124630
0
Patent Citations Received
Patent Inventor Names
Gourab Bhattacharjee
0
Alexey Revenko
0
Robert A. MacLeod
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9315811 Methods for modulating kallikrein (KLKB1) expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
